baber/WOPTO huggingface dataset:
Patent MX-2020000375-A (MX)
Title: Tissue mechanical fragmentation device intended for the preparation of a composition of isolated cells, and corresponding method.
Inventor: ROCHE RÉGIS
IPC: C12M1/33
Filed: 2018-07-12
Abstract: The invention relates to a device for the mechanical fragmentation of use which is intended for the preparation of the composition of isolated cells, notably adipocytes, from a tissue sample of tissues, notably obtained during liposuction, the said preparation comprising at least one step of mechanical fragmentation of the tooth use in the device, the said device comprising a motorized support (3) and a container (1), the motorized support (3) comprising a motor having a rotor secured to a coupling member, the container (1) internally comprising a rotary shaft (9) that can be set in axial rotation and comprises radial arms (10, 12) capable of sweeping the inside of the container (1) as the rotary shaft (9) rotates, the motorized support (3) and the container (1) comprising complementary securing means (11) that allow the container (1) to be immobilized on the motorized support (3), the coupling member and the rotary shaft (9) being configured in such a way as to allow axial rotation of the rotary shaft (9) when the rotor of the motor is turning. According to the invention, the radial arms (10, 12) are of two types: rigid vane-type arms (10), and flexible filamentary-type arms (12), notably made of nylon or of metal. A method completes the invention.
Patent MX-2020002932-A (MX)
Title: Travel assistance method and travel assistance device.
Inventor: SUNDA TAKASHI
IPC: G08G1/16
Filed: 2017-09-20
Abstract: In this travel assistance method and this travel assistance device, a driver of a vehicle which is capable of switching between manual driving by the driver and automatic driving is identified using driving characteristics during manual driving by the driver, and travel control corresponding to the identified driver is performed.
Patent MX-2020004472-A (MX)
Inventor: WERNER STEFAN
IPC: A61P25/00
Filed: 2018-10-24
Abstract: Un compuesto de la fórmula (I) ver fórmula o un N-óxido, una sal, un hidrato, un solvato, un tautómero o un estereoisómero de dicho compuesto, o una sal de dicho N óxido, tautómero o estereoisómero para uso en el tratamiento o la preención de isquemia cerebral, lesión cerebral isquémica, acódenle cerel3roescubr isquémico (IS), accidente cerebrovascular hemorrágico, lesión cerebral traumática, lesión de la médula espinal.
Patent MX-2020004567-A (MX)
Inventor: GUAN YINGHUI
IPC: G01N33/574
Filed: 2018-11-05
Abstract: La presente invención proporciona métodos diagnósticos, métodos terapéuticos y composiciones para el tratamiento del cáncer (p. ej., un cáncer de vejiga (p. ej., UC, p. ej., mUC), un cáncer de riñón, un cáncer de pulmón, un cáncer de hígado, un cáncer de ovario, un cáncer pancreático, un cáncer colorrectal o un cáncer de mama). La invención se basa, al menos en parte, en el descubrimiento de que los niveles de expresión de uno o más biomarcadores descritos en la presente en una muestra de un individuo que tiene cáncer se pueden usar en métodos para identificar a un individuoque tiene un cáncer que puede beneficiarse con una terapia contra el cáncer que incluye una inmunoterapia (p. ej., un antagonista de unión al eje PD-L1 como un anticuerpo anti-PD L1 (p. ej., atezolizumab)) y un antagonista estromal supresor (p. ej., un antagonista de TGF-ß), métodos para seleccionar una terapia para un individuo que tiene cáncer, métodos para tratar a un individuo que tiene cáncer, métodos para evaluar una respuesta o monitorear la respuesta de un individuo al tratamiento con una terapia contra el cáncer que incluye una inmunoterapia (p. ej., un antagonista de unión al eje PD-L1 como un anticuerpo anti-PD-L1 (p. ej., atezolizumab)) y un antagonista estromal supresor (p. ej., un antagonista de TGF-ß), y kits, terapias contra el cáncer y usos relacionados.
Patent MX-2020007011-A (MX)
Title: Modified vaccinia vectors.
Inventor: BELL JOHN C
IPC: A61P35/00
Filed: 2019-01-04
Abstract: The disclosure relates to modified vaccinia virus vectors derived from the Copenhagen strain of vaccinia virus, as well as methods of using the same for the treatment of various cancers. The disclosure provides modified Copenhagen-derived vaccinia virus vectors that exhibit various beneficial therapeutic activities, including enhanced oncolytic activity, spread of infection, immune evasion, tumor persistence, capacity for incorporation of exogenous DNA sequences, amenability for large scale manufacturing, and safety.
Patent MX-2020008197-A (MX)
Title: Battery pack containing a rotatable connector.
Inventor: ZHAO JIAN GUO
IPC: H01M50/509
Filed: 2018-02-12
Abstract: A battery pack comprising a frame and two or more battery cells installed to the frame. The two or more battery cells are interconnected by a rotatable connector which is configured to enable electrical connections between the two or more battery cells. The rotatable connector is adapted to be switched between at least a first rotational position in which the two or more battery cells being electrically connected, and a second rotational position, in which the two or more battery cells being not electrically connected. When the user actuates the knob on the battery pack, the connecting terminals change their rotational positions from a non-conducting position to a conducting position, thereby enabling the electrical connections between the groups of battery cells.
Patent MX-2020008707-A (MX)
Title: Heterogeneous mobile radio arrangement for supplying at least one mobile radio cell with mobile radio services.
Inventor: MOHR MARKUS
IPC: H04W88/08
Filed: 2019-02-20
Abstract: A heterogeneous mobile radio arrangement (1) comprises an antenna arrangement (8). There is provision for at least one screened supply cable (3) having a first and a second end (3a, 3b), said supply cable being designed to supply the at least one antenna arrangement (8) with electric power, wherein an AISG signal and mobile radio signals are transferrable via the at least one screened supply cable (3). There is provision for a first and a second IP converter (10a, 10b) and a first IP device (11, 11a, 11b, 11c), wherein both IP converters (10a, 10b) have a respective IP connection (30) and at least one respective signal line connection (31a, 31b). The first IP converter (10a) is connected by its IP connection (30) to a superordinate IP network (6), and the second IP converter (10b) is connectable by its IP connection (30) to the at least one first IP device (11, 11a, 11b, 11c). The at least one signal line connection (31a) of the first IP converter (10a) and the at least one signal line connection (31a) of the second IP converter (10b) are electrically connected by means of the screened supply cable (3).
Patent MX-2020010106-A (MX)
Title: Ultra-small form factor optical connector and adapter.
Inventor: TAKANO KAZUYOSHI
IPC: G02B6/36
Filed: 2019-01-16
Abstract: An optical connector holding two or more LC-type optical ferrules is provided. The optical connector includes an outer body, an inner front body accommodating the two or more LC-type optical ferrules, ferrule springs for urging the optical ferrules towards a mating receptacle, and a back body for supporting the ferrule springs. The outer body and the inner front body are configured such that four LC-type optical ferrules are accommodated in a small form-factor pluggable (SFP) transceiver footprint or eight LC-type optical ferrules are accommodated in a quad small form-factor pluggable (QSFP) transceiver footprint. A mating receptacle (transceiver or adapter) includes internal alignment slots configured to accept a corresponding alignment key on connector outer housing to ensure alignment and orientation for maximum signal transfer between opposing ferrule end faces.
Patent MX-2020010723-A (MX)
Title: C-type natriuretic peptide engrafted antibodies.
Inventor: WILMEN ANDREAS
IPC: C07K14/58
Filed: 2019-04-10
Abstract: The present invention relates to an antibody or a fragment thereof comprising at least one heterologous amino acid sequence incorporated within at least one CDR region of said antibody or fragment thereof, wherein said at least one heterologous amino acid sequence comprises an N-terminal linker sequence (Ntls), a C-Type Natriuretic Peptide (CNP) and a C-terminal linker sequence (Ctls). Optionally, at least a portion of said at least one CDR region is replaced by said at least one heterologous amino acid sequence incorporated therein. The present invention further relates to such antibody or fragment thereof for use in a method for treatment, a composition comprising such antibody or fragment thereof, a nucleic acid or a mixture of nucleic acids encoding such antibody or fragment thereof, a host cell comprising such nucleic acid or such mixture of nucleic acids and to a process for producing such antibody or fragment thereof.
Patent MX-2020011022-A (MX)
Title: X-ray fluorescence analyzer, and a method for performing x-ray fluorescence analysis.
Inventor: KOSKINEN TOMMI
IPC: G21K1/06
Filed: 2018-04-20
Abstract: An X-ray fluorescence analyzer comprises an X-ray tube (402) for emitting incident X-rays (206) in the direction of a first optical axis (204). A slurry handling unit (201) is configured to maintain a constant distance between a sample (202) of slurry and said X-ray tube. A first crystal diffractor (601) is located in a first direction from said slurry handling unit (201),and configured to separate a predefined first wavelength range from fluorescent X-rays (207) that propagate into said first direction. The first crystal diffractor is configured to direct the fluorescent X-rays in the separated predefined first wavelength range to a first radiation detector (602, 1505). The first crystal diffractor (601) comprises a pyrolytic graphite crystal (603, 802, 804) that has a diffractive surface (801, 803, 805),which is a simply connected surface. Said first radiation detector (602) is a solid-state semiconductor detector.
Patent MX-2020012306-A (MX)
Title: A system and method for short response time data services through cellular networks.
Inventor: BEN YIZHAK ELI
IPC: H04W76/45
Filed: 2019-04-28
Abstract: A User Equipment (UE) comprising: a modem capable of connecting to a Universal Mobile Telecommunications System (UMTS) cellular network for transmitting and receiving data, the modem having an idle state, one or more intermediate states, and a dedicated channel state, wherein: (a) in the idle state the modem is not connected to the UMTS cellular network, (b) in the dedicated channel state the modem is connected to the UMTS cellular network via a dedicated communication channel, and (c) in each of the intermediate states the modem is not connected to the UMTS cellular network via the dedicated communication channel and a first time-period required to transition from the corresponding intermediate state to the dedicated channel state is shorter than a second time-period required to transition from the idle state to the dedicated channel state; and a processing resource configured to: maintain a state transitioning regime of the UE, wherein the state transitioning regime includes: (a) preventing at least one transition of the UE to an idle state for at least one time-period; and (b) periodically transitioning the UE to the idle state, thereby enabling the modem to switch from the UMTS cellular network to the LTE cellular network.
Patent MX-2020013737-A (MX)
Title: Photocatalytic activity of titanium oxide with vanadium ions in the degradation of 2,4-d.
Inventor: MORENO RODRIGUEZ JOSÉ ALBINO
IPC: B01J21/06
Filed: 2020-12-15
Abstract: The present invention discloses a method for degrading the 2,4-di-chlorophenyl-acetic herbicide, consisting of the synthesis of nanoparticles of titanium oxide and titanium oxide doped with 1% vanadium at a reflux temperature of up to 363.15K by the sol-gel technique by thermal treatment at 773.15K under helium flow, obtaining the anatase form of titanium oxide and its contact in the presence of ultraviolet light with an aqueous sample containing 2,4-di-chlorophenyl-acetic acid.
Patent MX-2021000204-A (MX)
Title: Polyamide compositions and plating applications thereof.
Inventor: WHITE KIMBERLY M
IPC: C23C18/22
Filed: 2019-06-27
Abstract: The present disclosure relates to polyamide compositions and resulting injection-molded articles that can be plated, e.g., metal coated, to form aesthetic injection-molded articles. The polyamide compositions may include from 45 wt.% to 75 wt.% of an polyamide, from 2 wt.% to 40 wt.% of an etchable filler, from 10 wt.% to 40 wt.% of a semi-structural mineral, and optionally from 0.1 wt.% to 13 wt.% of additive. The polyamide composition imparts very good surface appearance to injection-molded articles that are substantially free of visual defects.
Patent MX-2021001742-A (MX)
Title: Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound.
Inventor: GUTHRIE WENDELL
IPC: A61P15/02
Filed: 2016-06-17
Abstract: The present disclosure relates to compositions and methods for inhibiting inflammation and reducing the risk of spreading sexually transmitted diseases using an alginic acid-based antimicrobial compound. Such compositions provide dual protection by (1) attacking and inactivating viruses and other microbes and (2) blocking the host response that viruses trigger to invade host cells. Such compositions can also be part of an acid buffering contraceptive.
Patent MX-2021002682-A (MX)
Title: Reusable wrapping system for securing goods stowed on pallets.
Inventor: VALDEZ HERNANDEZ JOSÉ FELIPE
IPC: B65D17/00
Filed: 2021-03-05
Abstract: The present invention relates to a complete reusable wrapping system with a versatile shape that wraps an entire load of products or merchandise stowed on a pallet. It aims to protect and secure the load, reducing the instability that its mobilization causes. Also, it consists of adjustable and flexible components for various dimensions in terms of thickness and height since it has a novel size modification mechanism for securing loads with a wide range of elevation. Additionally, it includes an upper or central body, two lateral sections, and strips with an adjustment mechanism for securing irregular dimension loads. Further, it facilitates the installation, requiring one person for assembly, removal, and storage. The uninstalled and compacted system occupies a reduced volume, optimizing space and time for transport and storage.
Patent MX-2021003347-A (MX)
Title: Composite foam article.
Inventor: JIMENEZ VICTORIA
IPC: B32B5/28
Filed: 2019-09-25
Abstract: A composite foam article comprises a foam core layer presenting a first surface and a second surface facing opposite the first surface. A first polymeric bonding layer is disposed on the first surface, one or more first reinforcing layers comprising a plurality of fibers and a polymeric binder are disposed on the first polymeric bonding layer, and a first polymeric containment layer is disposed on the one or more first reinforcing layers. A second polymeric bonding layer is disposed on the second surface, one or more second reinforcing layers comprising a plurality of fibers and a polymeric binder are disposed on the second polymeric bonding layer, and a second polymeric containment layer is disposed on the one or more second reinforcing layers. At least one catch layer comprising particles of carbon is dispersed in and/or disposed between any of the aforementioned layers.
Patent MX-2021003931-A (MX)
Title: Compounds stabilizing amylases in liquids.
Inventor: WEBER HEIKE
IPC: C12N9/96
Filed: 2019-09-24
Abstract: Enzyme preparation comprising component (a): at least one compound according to general formula (I), wherein the variables of formula (i) are as follows: R<sup>1</sup> is selected from H and C<sub>1</sub>-C<sub>10</sub> alkylcarbonyl, wherein alkyl may be linear or branched and may bear one or more hydroxyl groups; R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup> are independently from each other selected from H, linear C<sub>1</sub>-C<sub>8</sub> alkyl, and branched C<sub>3</sub>-C<sub>8</sub> alkyl, C<sub>6</sub>-C<sub>10</sub>-aryl, non-substituted or substituted with one or more carboxylate or hydroxyl groups, and C<sub>6</sub>-C<sub>10</sub>-aryl-alkyl, wherein alkyl of the latter is selected from linear C<sub>1</sub>-C<sub>8</sub> alkyl or branched C<sub>3</sub>-C<sub>8</sub> alkyl, wherein at least one of R<sup>2</sup>, R<sup>3</sup>, and R<sup>4</sup> is not H component (b): at least one enzyme selected from the group of hydrolases (EC 3), preferably at least one enzyme selected from the group of amylases, more preferably at least one enzyme selected from the group of alpha-amylases (EC 3.2.1.1); and/or at least one enzyme is selected from proteases, preferably from subtilisin type proteases (EC 3.4.21.62); and optionally component (c): at least one compound selected from solvents, enzyme stabilizers different from component (a), and compounds stabilizing the liquid enzyme preparation as such.
Patent MX-2021004652-A (MX)
Title: Catalyst-adsorbent filter for air purification.
Inventor: CHEN CHEN
IPC: B01D53/86
Filed: 2019-10-22
Abstract: Disclosed in certain embodiments are catalyst-adsorbent compositions that include a metal oxide catalyst adapted for converting gaseous pollutants into chemical ly-benign species, and an adsorbent adapted for adsorbing the chemically-benign species together with other gaseous species and volatile organic compounds.
Patent MX-2021004825-A (MX)
Title: Insecticidal proteins.
Inventor: REYNOLDS CLARENCE MICHAEL
IPC: C07K14/195
Filed: 2019-10-18
Abstract: Compositions and methods for controlling plant pests are disclosed. In particular, novel chimeric insecticidal proteins having toxicity to at least coleopteran insect pests are provided. Nucleic acid molecules encoding the novel insecticidal proteins are also provided. Methods of making the insecticidal proteins and methods of using the insecticidal proteins and nucleic acids encoding the insecticidal proteins of the invention, for example in transgenic plants to confer protection from insect damage, are also disclosed.
Patent MX-2021009538-A (MX)
Title: Method for collision avoidance in transfer of network packets.
Inventor: LEIGHTON JOHN
IPC: H04B1/50
Filed: 2020-02-11
Abstract: A system for transmitting data over a communication network operating in an Ethernet or serial communication mode, where an Ethernet or serial cable is replaced by radios transmitting over an over-the-air radio link. The system includes computer processors that receive the data and assemble that data into smaller OTA data packets for delivery across the link and operating protocols that provide collision avoidance of OTA packets transmitted in an overlapping manner by radios on opposite sides of the over-the-air link. In a preferred mode the system operates in the 902-928MHz ISM band, and the data being transmitted over distances much greater than for 2.4GHz transmission.
Patent MX-2021010891-A (MX)
Title: Tangential viral filtration.
Inventor: BROWER KEVIN
IPC: C12M3/06
Filed: 2020-03-11
Abstract: Viral filters include a filter member featuring a first surface and a second surface and having a thickness extending between the first and second surfaces in a first direction, and a plurality of channels formed in the filter member, each of the channels having a channel axis, where during use, a solution carrying a viral load flows in a direction parallel to the first surface, and at least a portion of the viral load enters the membrane through the first surface and propagates in the first direction, and where for at least 50% of the channels in the filter member, the channel axis is oriented at an angle of between 5 degrees and 85 degrees relative to the first direction.
Patent MX-2021012024-A (MX)
Title: Device for acting on at least parts of a body.
Inventor: GERSTENMEIER JÜRGEN
IPC: G06F3/16
Filed: 2020-04-02
Abstract: The invention relates to a device for acting on at least parts of the body of a user, in particular with medical-cosmetic radiation and/or by mechanical influence, comprising means for acting (22, 23) on the human body, which have adjustable operating parameters, and a controller (38), which is connected to the means for acting (22, 23) and sets the operating parameters. A device for acting on at least parts of the body of a user, which device can be adjusted to the needs of the user, in particular even during operation, is provided according to the invention in that at least one microphone is provided, by means of which voice inputs of the user for controlling the operating parameters can be captured, and in that the microphone is connected to an evaluation unit, which converts voice inputs captured by the microphone into control commands for the means for acting (22, 23). (Fig. 1).
Patent MX-2022002993-A (MX)
Title: Rebamipide for use in prevention and/or treatment of arterial stiffness.
Inventor: DANEK IVAN
IPC: A61K31/4704
Filed: 2020-09-10
Abstract: The present invention relates to the use of rebamipide in a method of prevention and/or treatment of arterial stiffness and associated diseases, such as hypertension, heart failure, myocardial infarction, stroke, peripheral arterial disease, renal failure, and chronic kidney disease. Rebamipide may also be used in a method of increasing arterial elasticity.
Patent MX-2022004126-A (MX)
Title: Robotic system simulation engine.
Inventor: MENON SAMIR
IPC: G06G7/48
Filed: 2020-09-28
Abstract: Techniques are disclosed to use robotic system simulation to control a robotic system. In various embodiments, a communication indicating an action to be performed by a robotic element is received from a robotic control system. Performance of the action by the robotic element is simulated. A state tracking data is updated to reflect a virtual change to one or more state variables as a result of simulated performance of the action. Successful completion of the action by the robotic element is reported to the robotic control system.
Patent MX-2022005391-A (MX)
Title: Grid-like fractal distributor or collector element.
Inventor: HIRSCHBERG SEBASTIAN
IPC: B01D3/00
Filed: 2020-10-10
Abstract: The present invention relates to a distributor element and/or collector element for uniformly distributing a first fluid, such as liquid, on a cross-sectional plane, such as on a cross-sectional plane of a mass transfer column, wherein a second main fluid, such as gas, flows in co-current flow and/or in counter-current flow with regard to the first fluid through the distributor element, wherein the distributor element comprises at least two levels separated from each other by fractal plates comprising openings and apertures, wherein each level comprises channels to be flowed through by the second main fluid and between the channels one or more flow path(s), through which the first fluid may flow, wherein the number of openings increases from the uppermost fractal plate to the lowest fractal plate, wherein the channels to be flowed through by the second main fluid are fluid-tightly separated by the walls from all of the one or more hollow spaces defining the fluid paths, through which the first fluid may flow, and wherein each of the fluid paths has at least substantially the same length, wherein substantially the same length means that each of the fluid paths of the level does not vary more in the length compared to the length of any other fluid path of the same level by more than 20%.
Patent MX-2022006319-A (MX)
Title: Immune cell delivery of sialidase to cancer cells, immune cells and the tumor microenvironment.
Inventor: CHANG NANCY T
IPC: A61K35/17
Filed: 2020-11-24
Abstract: The present application provides methods and compositions for treating cancers (such as solid tumors) using engineered immune cells encoding a sialidase and a chimeric immune receptor. In some embodiments, the engineered immune cell is a CAR-T, CAR-NK, CAR-M, or CAR-NKT cell. In some embodiments, the sialidase is an <i>Actinomyces viscosus</i> sialidase or a derivative thereof, such as DAS 181. In some embodiments, the methods and compositions provided herein reduce sialylation of tumor cells and/or immune cells.